A cache of internal emails offers a look at the pressure the nation’s public health officials faced from the new health secretary in the early months of the Trump administration.

The court’s decision is likely to determine the future of thousands of lawsuits against Bayer, which manufactures the weedkiller, over similar claims.

Doctors are contending with low supplies and unfilled orders of generic chemotherapy infusions that are central to the treatment of a long list of cancers.

Scientists believe that the Bundibugyo virus persists in an animal species, occasionally spilling over into humans. But they have yet to identify the species.

The patient had traveled to the Democratic Republic of Congo, the health ministry said. Workers are racing to trace those who may have had contact.

That is good news for patients, but officials fear it will make controlling the spread of the disease harder.

The Justice Department is taking aim at pricey “skin substitutes,” an overused wound care treatment that cost the government $10 billion in 2024.

Artificial intelligence programs can spot patterns in electrocardiograms that humans miss. Now, one program is going to be widely available — for free — to doctors.

Activists said more action was needed to solve the larger problem: Only 12 percent of Pakistani women and girls use safe, commercially made menstrual products.

A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, may give some families around the world an unlikely lifeline.

The White House recently endorsed monitoring sewage for evidence of drug use. Critics fear such efforts could violate privacy and stigmatize neighborhoods.

Following the pandemic, the federal government is spending $150 million on new technology to ensure clean indoor air. Here’s what scientists are pursuing.

It’s hot in North America in June, but fans are griping that the breaks that have been added to each half are an excuse for the networks to show more ads.